Skip to main content
. 2018 Apr 3;52(3):171–178. doi: 10.4132/jptm.2018.04.03

Table 3.

Diagnostic categories of thyroid FNAC according to variant of PTC

FNAC diagnostic category Variants of PTC in final diagnosis
Conventional NIFTP Invasive encapsulated follicular variant Infiltrative follicular variant Tall cell variant Other rare variants
Non-diagnostic 32 (2.2) 1 (4.0) 4 (8.8) 5 (7.7) 3 (2.8) 2 (11.8)
Benign 6 (0.4) 5 (20.0) 4 (8.8) 1 (1.6) 0 0
AUS 144 (10.0) 14 (56.0) 17 (37.8) 25 (40.3) 8 (7.5) 3 (17.6)
 AUS-NA 135 (9.3) 9 (36.0) 11 (24.4) 21 (33.9) 7 (6.6) 2 (11.8)
 AUS-MF 3 (0.2) 5 (20.0) 5 (11.1) 4 (6.4) 0 0
 AUS-HC 0 0 0 0 0 0
 AUS-others 6 (0.4) 0 1 (2.2) 0 1 (0.9) 1 (5.9)
Follicular neoplasm 0 2 (8.0) 2 (8.3) 1 (1.6) 0 0
Suspicious for malignancy 339 (23.5) 3 (12.0) 10 (4.4) 14 (22.6) 20 (18.9) 1 (5.9)
Malignant 924 (63.9) 0a 8 (17.8)a 16 (25.8) 75 (70.8) 11 (64.7)
Total No. 1,445 25 45 62 106 17

Values are presented as number (%).

FNAC, fine needle aspiration cytology; PTC, papillary thyroid carcinoma; NIFTP, noninvasive follicular thyroid neoplasm with papillary-like nuclear features; AUS, atypia of undetermined significance; NA, nuclear atypia; MF, microfollicles; HC, Hurthle cells.

a

p = .044, Fisher exact test.